Prevention of distal embolization during saphenous vein graft lesion angioplasty: Experience with a new temporary occlusion and aspiration system

Circulation

Volumn 99, Issue 25, 1999, Pages 3221-3223

  Carlino, Mauro ^a   De Gregorio, Joseph ^b   Di Mario, Carlo ^a,b   Anzuini, Angelo ^a   Airoldi, Flavio ^a   Albiero, Remo ^b   Briguori, Carlo ^a   Dharmadhikari, Aniruddha ^a   Sheiban, Imad ^a   Colombo, Antonio ^a,b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c EMO GVM Centro Cuore   (Italy)

Author keywords

Angioplasty; Embolism; Grafting; Veins

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; TICLOPIDINE; UROKINASE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BALLOON DILATATION; CORONARY ARTERY BYPASS GRAFT; DEVICE; EMBOLISM; FEMALE; GRAFT OCCLUSION; GUIDE WIRE; HEART EJECTION FRACTION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; Q WAVE; SAPHENOUS VEIN GRAFT; STENT;

EID: 0033614805     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.25.3221     Document Type: Article

References (9)

1. Bourassa MG, Fischer LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation. 1985;72(suppl V):V-71-V-78.
2. Cameron A, Kemp HG Jr, Green GE. Reoperation for coronary artery disease: 18 years of clinical follow-up. Circulation. 1988;78:(suppl I):I-158-I-162.
3. Hartmann J, McKeever L, Teran J. Prolonged infusion of urokinase for recanalization of chronically occluded aortocoronary bypass graft. Am J Cardiol. 1988;61:189-191.
4. Safian RD, Grines CL, May MA, Lichtenberg A, Juran N, Schreiber TL, Pavlides G, Meany TB, Savas V, O'Neil WW. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation. 1994;89:302-312.
5. Holmes DR Jr, Topol EJ, Califf RM, Berdan LG, Leya F, Berger PB, Whitlow PL, Safian RD, Adelman AG, Kellet MA Jr, Talley D III, Shani J, Gottlieb RS, Pinkerton CA, Lee KL, Keeler GP, Ellis SG, the CAVEAT-II Investigators. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. 1995;91:1966-1974.
6. Bittl JA, Sanborn TA, Yardley DE, Tcheng JE, Isner JM, Chokshi SK, Strauss BH, Abela GS, Walter PD, Schmidhofer M, Power JA, for the Percutaneous Excimer Laser Coronary Angioplasty Registry. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. Am J Cardiol. 1994;74:144-148.
7. Rosenschein U, Gaul G, Erbel R, Amann F, Velasguez D, Stoerger H, Reudiger S, Gomez G, Troster J, Bartorelli A, Peper M, Kyriakides Z, Laniado S, Miller HI, Cribier A, Fajadet J. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation. 1999;99:26-29.
8. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S, Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 1997;337:740-747.
9. Greckens U, Muller R, Cattelaens N, Herchenbach, Grube E. The new coronary stent graft JoStent: first clinical experience. J Am Coll Cardiol. 1998;31:414A. Abstract.